US Stock MarketDetailed Quotes

KPTI Karyopharm Therapeutics

Watchlist
  • 0.911
  • +0.021+2.38%
Close Jul 22 16:00 ET
  • 0.900
  • -0.011-1.23%
Post 17:54 ET
113.55MMarket Cap-717P/E (TTM)

Karyopharm Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-14.40%33.13M
-7.03%146.03M
0.50%33.75M
-0.38%36.01M
-5.29%37.58M
-18.82%38.7M
-25.14%157.07M
-73.41%33.58M
-4.10%36.15M
75.56%39.68M
Operating revenue
-14.40%33.13M
-7.03%146.03M
0.50%33.75M
-0.38%36.01M
-5.29%37.58M
-18.82%38.7M
-25.14%157.07M
-73.41%33.58M
-4.10%36.15M
75.56%39.68M
Cost of revenue
41.45%1.91M
-5.20%4.94M
-20.45%1.49M
-7.04%911K
27.16%1.19M
-5.26%1.35M
53.23%5.21M
151.75%1.87M
66.38%980K
-17.49%939K
Gross profit
-16.42%31.22M
-7.09%141.09M
1.73%32.26M
-0.19%35.1M
-6.08%36.39M
-19.24%37.35M
-26.43%151.86M
-74.74%31.71M
-5.22%35.17M
80.50%38.74M
Operating expense
-4.79%64.97M
-7.97%270.63M
6.84%70.07M
0.54%66.36M
-19.22%65.96M
-15.57%68.25M
-3.49%294.06M
-16.53%65.58M
-18.42%66M
15.79%81.65M
Selling and administrative expenses
-17.71%29.55M
-9.30%131.88M
-11.43%30.69M
-11.08%30.81M
-7.65%34.48M
-7.38%35.91M
1.08%145.4M
0.25%34.65M
-1.31%34.65M
2.21%37.34M
-General and administrative expense
-17.71%29.55M
-9.30%131.88M
-11.43%30.69M
-11.08%30.81M
-7.65%34.48M
-7.38%35.91M
1.08%145.4M
0.25%34.65M
-1.31%34.65M
2.21%37.34M
Research and development costs
9.54%35.43M
-6.67%138.75M
27.31%39.38M
13.37%35.55M
-28.96%31.48M
-23.12%32.34M
-7.57%148.66M
-29.70%30.93M
-31.54%31.36M
30.39%44.31M
Operating profit
-9.26%-33.76M
8.90%-129.54M
-11.63%-37.81M
-1.37%-31.26M
31.08%-29.57M
10.66%-30.9M
-44.70%-142.2M
-172.12%-33.87M
29.61%-30.84M
12.52%-42.91M
Net non-operating interest income expense
-28.15%-3.73M
43.10%-12.88M
18.96%-3.69M
39.09%-3.32M
50.83%-2.96M
55.99%-2.91M
11.10%-22.64M
42.28%-4.55M
31.04%-5.46M
-24.48%-6.02M
Non-operating interest income
-24.32%2.16M
363.88%10.94M
88.91%2.52M
317.93%2.75M
863.82%2.82M
3,750.00%2.85M
305.33%2.36M
2,325.45%1.33M
571.43%658K
77.58%293K
Non-operating interest expense
2.19%5.88M
-4.69%23.82M
5.49%6.21M
-0.67%6.07M
-8.38%5.78M
-13.85%5.76M
-4.03%25M
-25.88%5.89M
-23.67%6.11M
26.23%6.31M
Other net income (expense)
174.24%196K
-328.92%-356K
-1,523.08%-211K
456.25%89K
330.77%30K
-261.64%-264K
2.35%-83K
97.28%-13K
-11.11%16K
-102.98%-13K
Other non- operating income (expenses)
174.24%196K
-328.92%-356K
-1,523.08%-211K
456.25%89K
330.77%30K
---264K
2.35%-83K
97.28%-13K
-11.11%16K
-102.98%-13K
Income before tax
-9.45%-37.29M
13.43%-142.78M
-8.52%-41.71M
4.92%-34.49M
33.59%-32.5M
17.44%-34.07M
-33.19%-164.92M
-199.57%-38.43M
29.84%-36.28M
8.43%-48.94M
Income tax
31.48%71K
-12.47%323K
78.08%130K
-73.33%12K
4.96%127K
-58.46%54K
37.69%369K
160.33%73K
-57.55%45K
-9.70%121K
Net income
-9.48%-37.36M
13.43%-143.1M
-8.65%-41.84M
5.00%-34.51M
33.49%-32.63M
17.57%-34.13M
-33.20%-165.29M
-199.45%-38.51M
29.89%-36.32M
8.44%-49.06M
Net income continuous Operations
-9.48%-37.36M
13.43%-143.1M
-8.65%-41.84M
5.00%-34.51M
33.49%-32.63M
17.57%-34.13M
-33.20%-165.29M
-199.45%-38.51M
29.89%-36.32M
8.44%-49.06M
Minority interest income
Net income attributable to the parent company
-9.48%-37.36M
13.43%-143.1M
-8.65%-41.84M
5.00%-34.51M
33.49%-32.63M
17.57%-34.13M
-33.20%-165.29M
-199.45%-38.51M
29.89%-36.32M
8.44%-49.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-9.48%-37.36M
13.43%-143.1M
-8.65%-41.84M
5.00%-34.51M
33.49%-32.63M
17.57%-34.13M
-33.20%-165.29M
-199.45%-38.51M
29.89%-36.32M
8.44%-49.06M
Basic earnings per share
-6.67%-0.32
38.12%-1.25
16.28%-0.36
33.33%-0.3
53.23%-0.29
43.40%-0.3
-22.42%-2.02
-184.31%-0.43
34.78%-0.45
12.68%-0.62
Diluted earnings per share
-6.67%-0.32
38.12%-1.25
16.28%-0.36
33.33%-0.3
53.23%-0.29
43.40%-0.3
-22.42%-2.02
-193.48%-0.43
34.78%-0.45
12.68%-0.62
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -14.40%33.13M-7.03%146.03M0.50%33.75M-0.38%36.01M-5.29%37.58M-18.82%38.7M-25.14%157.07M-73.41%33.58M-4.10%36.15M75.56%39.68M
Operating revenue -14.40%33.13M-7.03%146.03M0.50%33.75M-0.38%36.01M-5.29%37.58M-18.82%38.7M-25.14%157.07M-73.41%33.58M-4.10%36.15M75.56%39.68M
Cost of revenue 41.45%1.91M-5.20%4.94M-20.45%1.49M-7.04%911K27.16%1.19M-5.26%1.35M53.23%5.21M151.75%1.87M66.38%980K-17.49%939K
Gross profit -16.42%31.22M-7.09%141.09M1.73%32.26M-0.19%35.1M-6.08%36.39M-19.24%37.35M-26.43%151.86M-74.74%31.71M-5.22%35.17M80.50%38.74M
Operating expense -4.79%64.97M-7.97%270.63M6.84%70.07M0.54%66.36M-19.22%65.96M-15.57%68.25M-3.49%294.06M-16.53%65.58M-18.42%66M15.79%81.65M
Selling and administrative expenses -17.71%29.55M-9.30%131.88M-11.43%30.69M-11.08%30.81M-7.65%34.48M-7.38%35.91M1.08%145.4M0.25%34.65M-1.31%34.65M2.21%37.34M
-General and administrative expense -17.71%29.55M-9.30%131.88M-11.43%30.69M-11.08%30.81M-7.65%34.48M-7.38%35.91M1.08%145.4M0.25%34.65M-1.31%34.65M2.21%37.34M
Research and development costs 9.54%35.43M-6.67%138.75M27.31%39.38M13.37%35.55M-28.96%31.48M-23.12%32.34M-7.57%148.66M-29.70%30.93M-31.54%31.36M30.39%44.31M
Operating profit -9.26%-33.76M8.90%-129.54M-11.63%-37.81M-1.37%-31.26M31.08%-29.57M10.66%-30.9M-44.70%-142.2M-172.12%-33.87M29.61%-30.84M12.52%-42.91M
Net non-operating interest income expense -28.15%-3.73M43.10%-12.88M18.96%-3.69M39.09%-3.32M50.83%-2.96M55.99%-2.91M11.10%-22.64M42.28%-4.55M31.04%-5.46M-24.48%-6.02M
Non-operating interest income -24.32%2.16M363.88%10.94M88.91%2.52M317.93%2.75M863.82%2.82M3,750.00%2.85M305.33%2.36M2,325.45%1.33M571.43%658K77.58%293K
Non-operating interest expense 2.19%5.88M-4.69%23.82M5.49%6.21M-0.67%6.07M-8.38%5.78M-13.85%5.76M-4.03%25M-25.88%5.89M-23.67%6.11M26.23%6.31M
Other net income (expense) 174.24%196K-328.92%-356K-1,523.08%-211K456.25%89K330.77%30K-261.64%-264K2.35%-83K97.28%-13K-11.11%16K-102.98%-13K
Other non- operating income (expenses) 174.24%196K-328.92%-356K-1,523.08%-211K456.25%89K330.77%30K---264K2.35%-83K97.28%-13K-11.11%16K-102.98%-13K
Income before tax -9.45%-37.29M13.43%-142.78M-8.52%-41.71M4.92%-34.49M33.59%-32.5M17.44%-34.07M-33.19%-164.92M-199.57%-38.43M29.84%-36.28M8.43%-48.94M
Income tax 31.48%71K-12.47%323K78.08%130K-73.33%12K4.96%127K-58.46%54K37.69%369K160.33%73K-57.55%45K-9.70%121K
Net income -9.48%-37.36M13.43%-143.1M-8.65%-41.84M5.00%-34.51M33.49%-32.63M17.57%-34.13M-33.20%-165.29M-199.45%-38.51M29.89%-36.32M8.44%-49.06M
Net income continuous Operations -9.48%-37.36M13.43%-143.1M-8.65%-41.84M5.00%-34.51M33.49%-32.63M17.57%-34.13M-33.20%-165.29M-199.45%-38.51M29.89%-36.32M8.44%-49.06M
Minority interest income
Net income attributable to the parent company -9.48%-37.36M13.43%-143.1M-8.65%-41.84M5.00%-34.51M33.49%-32.63M17.57%-34.13M-33.20%-165.29M-199.45%-38.51M29.89%-36.32M8.44%-49.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -9.48%-37.36M13.43%-143.1M-8.65%-41.84M5.00%-34.51M33.49%-32.63M17.57%-34.13M-33.20%-165.29M-199.45%-38.51M29.89%-36.32M8.44%-49.06M
Basic earnings per share -6.67%-0.3238.12%-1.2516.28%-0.3633.33%-0.353.23%-0.2943.40%-0.3-22.42%-2.02-184.31%-0.4334.78%-0.4512.68%-0.62
Diluted earnings per share -6.67%-0.3238.12%-1.2516.28%-0.3633.33%-0.353.23%-0.2943.40%-0.3-22.42%-2.02-193.48%-0.4334.78%-0.4512.68%-0.62
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg